Figure 2
From: Mesenchymal stem cells with rhBMP-2 inhibits the growth of canine osteosarcoma cells
Pluripotent embryonic stem cell markers. Expression of pluripotent embryonic stem cell markers (Nanog and Oct 3/4) and markers of mesenchymal stem cells with osteogenic potential (Stro-1 and CD90) in OST cells (A) and cMSCs (B) from the control and the group treated with rhBMP-2 (5 nM e 20 nM respectively) for 120 h. Statistical differences were obtained by analysis of variance (*** p < 0.001, ** p < 0.01).